• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD ACETLR CUP HAP 60MM W/ IMPTR; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD ACETLR CUP HAP 60MM W/ IMPTR; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Model Number 74120160
Medical Device Problem Code Biocompatibility (2886)
Health Effect - Clinical Codes Pain (1994); Joint Dislocation (2374); Metal Related Pathology (4530)
Date of Event 01/13/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, after left bhr surgery was performed on (b)(6) 2011, the patient experienced metallosis, pain, instability, and three dislocations.This adverse event was treated with revision surgery and open biopsy on (b)(6) 2022.After this procedure, the patient was transported to the recovery room in stable condition.In addition, the patient had previously underwent a primary right bhr surgery on (b)(6) 2007, however, no complications have been reported regarding the right hip.
 
Additional Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Additional Manufacturer Narrative
It was reported that left hip revision surgery was performed.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the femoral head and acetabular cup was performed using batch numbers to evaluate patterns of repeated failures or defects over the lifetime of the product and using part numbers and the reported failure modes to evaluate patterns of repeated failures or defects in a timeframe prior 12 months as of the complaint aware date.No other complaints were identified to involve the femoral head batch number; nonetheless, other complaints were identified to involve the acetabular cup batch number.Other similar complaints were identified for the part number and the reported/related failure mode of the femoral head and the acetabular cup.This failure will continue to be monitored.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, no prior applicable escalation actions were identified.The available medical documents were reviewed.With the information provided, the revision intraoperative findings of absence of posterior capsule of the hip cannot be ruled out as a contributing factor to the reported dislocations.The pain, elevated serum and synovial metal ions, dark reddish black fluid, and absence of posterior capsule of the hip may be consistent with the reported metallosis; however, with the information provided the clinical root cause of the reported clinical reactions/ events cannot be confirmed, and it cannot be concluded that the reported clinical reactions/events were associated with a mal performance of the implant.Repeated dislocations with metal on metal components can also lead to metal debris and wear.Based on the available information we can confirm the reported complaint, however without further information our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACETLR CUP HAP 60MM W/ IMPTR
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key14493712
Report Number3005975929-2022-00332
Device Sequence Number12161170
Product Code NXT
UDI-Device Identifier03596010502612
UDI-Public03596010502612
Combination Product (Y/N)N
Initial Reporter StateMD
Initial Reporter CountryUS
PMA/510(K) Number
P040033
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Device Explanted Year2022
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/01/2016
Device Model Number74120160
Device Catalogue Number74120160
Device Lot Number11EW33044
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/02/2022
Supplement Date Received by Manufacturer09/22/2022
Initial Report FDA Received Date05/25/2022
Supplement Report FDA Received Date09/23/2022
Date Device Manufactured05/14/2011
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age71 YR
Patient SexMale
-
-